Detection of Nucleocapsid Antibodies Associated with Primary SARS-CoV-2 Infection in Unvaccinated and Vaccinated Blood Donors

Nucleocapsid antibody assays can be used to estimate SARS-CoV-2 infection prevalence in regions implementing spike-based COVID-19 vaccines. However, poor sensitivity of nucleocapsid antibody assays in detecting infection after vaccination has been reported. We derived a lower cutoff for identifying...

全面介紹

書目詳細資料
發表在:Emerging Infectious Diseases
Main Authors: Eduard Grebe, Mars Stone, Bryan R. Spencer, Akintunde Akinseye, David Wright, Clara Di Germanio, Roberta Bruhn, Karla G. Zurita, Paul Contestable, Valerie Green, Marion C. Lanteri, Paula Saa, Brad J. Biggerstaff, Melissa M. Coughlin, Steve Kleinman, Brian Custer, Jefferson M. Jones, Michael P. Busch
格式: Article
語言:英语
出版: Centers for Disease Control and Prevention 2024-08-01
主題:
在線閱讀:https://wwwnc.cdc.gov/eid/article/30/8/24-0659_article